These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1081 related articles for article (PubMed ID: 15659495)
1. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study. Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan. Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736 [TBL] [Abstract][Full Text] [Related]
3. Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. Sørbye H; Glimelius B; Berglund A; Fokstuen T; Tveit KM; Braendengen M; Øgreid D; Dahl O J Clin Oncol; 2004 Jan; 22(1):31-8. PubMed ID: 14701765 [TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M; J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952 [TBL] [Abstract][Full Text] [Related]
5. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076 [TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study. Pectasides D; Pectasides M; Farmakis D; Gaglia A; Koumarianou A; Nikolaou M; Koumpou M; Kountourakis P; Papaxoinis G; Mitrou P; Economopoulos T; Raptis SA Gynecol Oncol; 2004 Oct; 95(1):165-72. PubMed ID: 15385127 [TBL] [Abstract][Full Text] [Related]
7. Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study. François E; Berdah JF; Chamorey E; Lesbats G; Teissier E; Codoul JF; Badetti JL; Hébert C; Mari V Cancer Chemother Pharmacol; 2008 Nov; 62(6):931-6. PubMed ID: 18273618 [TBL] [Abstract][Full Text] [Related]
8. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145 [TBL] [Abstract][Full Text] [Related]
9. A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites. Oh SY; Kwon HC; Lee S; Lee DM; Yoo HS; Kim SH; Jang JS; Kim MC; Jeong JS; Kim HJ Jpn J Clin Oncol; 2007 Dec; 37(12):930-5. PubMed ID: 18211984 [TBL] [Abstract][Full Text] [Related]
10. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer. Xiong JP; Zhang L; Zhong LX; Qiu F; Xu J; Tao QS; Xiang XJ; Yu F; Tang XM Anticancer Drugs; 2007 Oct; 18(9):1103-7. PubMed ID: 17704661 [TBL] [Abstract][Full Text] [Related]
11. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC). Link K; Happich K; Schirner I; Jüngert B; Brückl V; Männlein G; Brückl WM; Merkel S; Göhl J; Hohenberger W; Hahn EG; Wein A Anticancer Res; 2004; 24(1):385-91. PubMed ID: 15015625 [TBL] [Abstract][Full Text] [Related]
12. Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study). Hebbar M; Tournigand C; Lledo G; Mabro M; André T; Louvet C; Aparicio T; Flesch M; Varette C; de Gramont A; Cancer Invest; 2006 Mar; 24(2):154-9. PubMed ID: 16537184 [TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer. Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458 [TBL] [Abstract][Full Text] [Related]
14. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies. Viel E; Demarchi MF; Chaigneau L; Nguyen T; Legat C; Stein U; Thiery-Vuillemin A; Limat S; Pivot X; Borg C Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer. Chiara S; Nobile MT; Gozza A; Taveggia P; Heouaine A; Pastrone I; Percivale PL; Lionetto R; Sanguineti O; Rosso R Anticancer Res; 2004; 24(1):355-60. PubMed ID: 15015621 [TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer. Hochster H; Chachoua A; Speyer J; Escalon J; Zeleniuch-Jacquotte A; Muggia F J Clin Oncol; 2003 Jul; 21(14):2703-7. PubMed ID: 12860947 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer. Cao W; Yang W; Lou G; Jiang J; Geng M; Xi W; Li H; Ma T; Jin Y Anticancer Drugs; 2009 Apr; 20(4):287-93. PubMed ID: 19177020 [TBL] [Abstract][Full Text] [Related]
18. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. Fuchs CS; Marshall J; Mitchell E; Wierzbicki R; Ganju V; Jeffery M; Schulz J; Richards D; Soufi-Mahjoubi R; Wang B; Barrueco J J Clin Oncol; 2007 Oct; 25(30):4779-86. PubMed ID: 17947725 [TBL] [Abstract][Full Text] [Related]
19. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study. Tournigand C; Cervantes A; Figer A; Lledo G; Flesch M; Buyse M; Mineur L; Carola E; Etienne PL; Rivera F; Chirivella I; Perez-Staub N; Louvet C; André T; Tabah-Fisch I; de Gramont A J Clin Oncol; 2006 Jan; 24(3):394-400. PubMed ID: 16421419 [TBL] [Abstract][Full Text] [Related]
20. A phase II study of irinotecan with bi-weekly, low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as salvage therapy for patients with advanced or metastatic gastric cancer. Kim SG; Oh SY; Kwon HC; Lee S; Kim JH; Kim SH; Kim HJ Jpn J Clin Oncol; 2007 Oct; 37(10):744-9. PubMed ID: 17923456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]